First Patients Treated in a New Randomized Controlled Trial Evaluating the MISHA® Knee System vs. Non-Surgical Treatment for Knee Osteoarthritis
OrthoSpineNews
MAY 29, 2025
May 29, 2025 -( BUSINESS WIRE )- Moximed, an innovative medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced the first patients have been treated in a new randomized controlled trial (RCT) evaluating the MISHA Knee System compared to non-surgical treatments.
Let's personalize your content